A Systematic Review on Gut Microbiota in Type 2 Diabetes Mellitus

Overview

Journal Front Endocrinol (Lausanne)

Date 2025 Feb 3

PMID 39897957

Authors

Serena Chong

Mike Lin

Deborah Chong

Slade Jensen

Namson S Lau

Affiliations

Soon will be listed here.

Abstract

Aims/hypothesis: The gut microbiota play crucial roles in the digestion and degradation of nutrients, synthesis of biological agents, development of the immune system, and maintenance of gastrointestinal integrity. Gut dysbiosis is thought to be associated with type 2 diabetes mellitus (T2DM), one of the world's fastest growing diseases. The aim of this systematic review is to identify differences in the composition and diversity of the gut microbiota in individuals with T2DM.

Methods: A systematic search was conducted to identify studies reporting on the difference in gut microbiota composition between individuals with T2DM and healthy controls. Relevant studies were evaluated, and their characteristics and results were extracted using a standardized data extraction form. The studies were assessed for risk of bias and their findings were reported narratively.

Results: 58 observational studies published between 2010 and 2024 were included. Beta diversity was commonly reported to be different between individuals with T2DM and healthy individuals. Genera Lactobacillus, Escherichia-Shigella, Enterococcus, Subdoligranulum and Fusobacteria were found to be positively associated; while Akkermansia, Bifidobacterium, Bacteroides, Roseburia, Faecalibacteirum and Prevotella were found to be negatively associated with T2DM.

Conclusions: This systematic review demonstrates a strong association between T2DM and gut dysbiosis, as evidenced by differential microbial abundances and altered diversity indices. Among these taxa, is consistently associated with T2DM, whereas appears to offer a protective effect against T2DM. However, the heterogeneity and observational nature of these studies preclude the establishment of causative relationships. Future research should incorporate age, diet and medication-matched controls, and include functional analysis of these gut microbes.

Systematic Review Registration: https://www.crd.york.ac.uk/prospero/, identifier CRD42023459937.

References

Afolayan A, Adebusoye L, Cadmus E, Ayeni F . Insights into the gut microbiota of Nigerian elderly with type 2 diabetes and non-diabetic elderly persons. Heliyon. 2020; 6(5):e03971. PMC: 7262409. DOI: 10.1016/j.heliyon.2020.e03971. View

Feng Q, Liang S, Jia H, Stadlmayr A, Tang L, Lan Z . Gut microbiome development along the colorectal adenoma-carcinoma sequence. Nat Commun. 2015; 6:6528. DOI: 10.1038/ncomms7528. View

Al Bataineh M, Dash N, Bel Lassen P, Banimfreg B, Nada A, Belda E . Revealing links between gut microbiome and its fungal community in Type 2 Diabetes Mellitus among Emirati subjects: A pilot study. Sci Rep. 2020; 10(1):9624. PMC: 7295773. DOI: 10.1038/s41598-020-66598-2. View

Plovier H, Everard A, Druart C, Depommier C, Van Hul M, Geurts L . A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice. Nat Med. 2016; 23(1):107-113. DOI: 10.1038/nm.4236. View

Pesce M, DAlessandro A, Borrelli O, Gigli S, Seguella L, Cuomo R . Endocannabinoid-related compounds in gastrointestinal diseases. J Cell Mol Med. 2017; 22(2):706-715. PMC: 5783846. DOI: 10.1111/jcmm.13359. View

Kwan S, Sabotta C, Joon A, Wei P, Petty L, Below J . Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas. mSystems. 2022; 7(3):e0003322. PMC: 9238400. DOI: 10.1128/msystems.00033-22. View

Fusco W, Lorenzo M, Cintoni M, Porcari S, Rinninella E, Kaitsas F . Short-Chain Fatty-Acid-Producing Bacteria: Key Components of the Human Gut Microbiota. Nutrients. 2023; 15(9). PMC: 10180739. DOI: 10.3390/nu15092211. View

He Q, Niu M, Bi J, Du N, Liu S, Yang K . Protective effects of a new generation of probiotic Bacteroides fragilis against colitis in vivo and in vitro. Sci Rep. 2023; 13(1):15842. PMC: 10517118. DOI: 10.1038/s41598-023-42481-8. View

Dandona P, Aljada A, Bandyopadhyay A . Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol. 2003; 25(1):4-7. DOI: 10.1016/j.it.2003.10.013. View

10.

Mantovani A, Dalbeni A, Peserico D, Cattazzo F, Bevilacqua M, Salvagno G . Plasma Bile Acid Profile in Patients with and without Type 2 Diabetes. Metabolites. 2021; 11(7). PMC: 8304030. DOI: 10.3390/metabo11070453. View

11.

Huang D, Xiong M, Xu X, Wu X, Xu J, Cai X . Bile acids elevated by high-fat feeding induce endoplasmic reticulum stress in intestinal stem cells and contribute to mucosal barrier damage. Biochem Biophys Res Commun. 2020; 529(2):289-295. DOI: 10.1016/j.bbrc.2020.05.226. View

12.

Wu X, He B, Liu J, Feng H, Ma Y, Li D . Molecular Insight into Gut Microbiota and Rheumatoid Arthritis. Int J Mol Sci. 2016; 17(3):431. PMC: 4813281. DOI: 10.3390/ijms17030431. View

13.

Gravdal K, Kirste K, Grzelak K, Kirubakaran G, Leissner P, Saliou A . Exploring the gut microbiota in patients with pre-diabetes and treatment naïve diabetes type 2 - a pilot study. BMC Endocr Disord. 2023; 23(1):179. PMC: 10440924. DOI: 10.1186/s12902-023-01432-0. View

14.

Rubinstein M, Wang X, Liu W, Hao Y, Cai G, Han Y . Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/β-catenin signaling via its FadA adhesin. Cell Host Microbe. 2013; 14(2):195-206. PMC: 3770529. DOI: 10.1016/j.chom.2013.07.012. View

15.

Tamura A, Murabayashi M, Nishiya Y, Mizushiri S, Hamaura K, Ito R . Interrelations between Gut Microbiota Composition, Nutrient Intake and Diabetes Status in an Adult Japanese Population. J Clin Med. 2022; 11(11). PMC: 9181032. DOI: 10.3390/jcm11113216. View

16.

Malek A, Ahmadi Badi S, Karimi G, Bizouarn T, Irian S, Siadat S . The effect of and its postbiotics on the expression of genes involved in the endocannabinoid system and intestinal epithelial integrity in Caco-2 cells. J Diabetes Metab Disord. 2023; 22(2):1417-1424. PMC: 10638345. DOI: 10.1007/s40200-023-01264-8. View

17.

Cani P, Bibiloni R, Knauf C, Waget A, Neyrinck A, Delzenne N . Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes. 2008; 57(6):1470-81. DOI: 10.2337/db07-1403. View

18.

Chen Y, Shen X, Ma T, Yu X, Kwok L, Li Y . Adjunctive Probio-X Treatment Enhances the Therapeutic Effect of a Conventional Drug in Managing Type 2 Diabetes Mellitus by Promoting Short-Chain Fatty Acid-Producing Bacteria and Bile Acid Pathways. mSystems. 2023; 8(1):e0130022. PMC: 9948714. DOI: 10.1128/msystems.01300-22. View

19.

Mooranian A, Negrulj R, Al-Salami H, Morahan G, Jamieson E . Designing anti-diabetic β-cells microcapsules using polystyrenic sulfonate, polyallylamine, and a tertiary bile acid: Morphology, bioenergetics, and cytokine analysis. Biotechnol Prog. 2016; 32(2):501-9. DOI: 10.1002/btpr.2223. View

20.

Zhou C, Wang Y, Li C, Xie Z, Dai L . Amelioration of Colitis by a Gut Bacterial Consortium Producing Anti-Inflammatory Secondary Bile Acids. Microbiol Spectr. 2023; :e0333022. PMC: 10101101. DOI: 10.1128/spectrum.03330-22. View